Skip to content
10-K

Annual Report

KIWA BIO-TECH PRODUCTS GROUP CORP

0001493152-20-010111

← back to feed
Filed
May 29, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · May 29, 2020 282.39M sh
Shares Diluted FY 2019 · Dec 31, 2019 22.81M sh
Shares Diluted FY 2019 · Dec 31, 2018 16.52M sh
Operating Cash Flow FY 2019 · Dec 31, 2019 $183.07K
Operating Cash Flow FY 2019 · Dec 31, 2018 −$1.65M
Cash And Equivalents FY 2019 · Dec 31, 2019 $7.97K
Cash And Equivalents FY 2019 · Dec 31, 2018 $7.86K
Stockholders Equity FY 2019 · Dec 31, 2019 $9.69M
Stockholders Equity FY 2019 · Dec 31, 2018 $12.73M
Stockholders Equity FY 2019 · Dec 31, 2017 $10.67M
Current Liabilities FY 2019 · Dec 31, 2019 $14.25M
Current Liabilities FY 2019 · Dec 31, 2018 $19.78M
Total Liabilities FY 2019 · Dec 31, 2019 $14.38M
Total Liabilities FY 2019 · Dec 31, 2018 $19.78M
Current Assets FY 2019 · Dec 31, 2019 $22.84M
Current Assets FY 2019 · Dec 31, 2018 $31.69M
Total Assets FY 2019 · Dec 31, 2019 $24.07M
Total Assets FY 2019 · Dec 31, 2018 $32.51M
Eps Diluted FY 2019 · Dec 31, 2019 −$0.29
Eps Diluted FY 2019 · Dec 31, 2018 $0.02
Eps Basic FY 2019 · Dec 31, 2019 −$0.29
Eps Basic FY 2019 · Dec 31, 2018 $0.02
Sga Expense FY 2019 · Dec 31, 2019 $4.38M
Sga Expense FY 2019 · Dec 31, 2018 $4.93M
Net Income FY 2019 · Dec 31, 2019 −$6.64M
Net Income FY 2019 · Dec 31, 2018 $343.82K
Operating Income FY 2019 · Dec 31, 2019 −$1.19M
Operating Income FY 2019 · Dec 31, 2018 $2.59M
Gross Profit FY 2019 · Dec 31, 2019 $9.33M
Gross Profit FY 2019 · Dec 31, 2018 $8.26M
Revenue FY 2019 · Dec 31, 2019 $40.09M
Revenue FY 2019 · Dec 31, 2018 $30.65M
Capex FY 2019 · Dec 31, 2018 $52.99K
Rd Expense FY 2019 · Dec 31, 2018 $122.77K